Yorkshire company develops early diagnostic test for lung cancer

A non-invasive diagnostic test for early-stage bronchial carcinoma (lung cancer) is one of the innovative technologies being presented at White Rose Bioscience Forum in York today (03 November).


Developed by Sheffield-based company Medis Diagnostics Ltd, the test – Fortel Bca – provides a reliable and accurate method of diagnosing early stage lung cancer through the analysis of a small blood sample which looks for cellular changes. The test uses data from a specially chosen panel of seven biomarkers, which, together with a patented ‘fuzzy logic’ mathematical process, provides the clinician with not only a benign/malignant diagnosis, but also a specific histology of any malignancy found. The test is cost-effective and offers high specificity and sensitivity and may bring diagnosis of lung cancer forward by up to 18 months.

Lung cancer is a difficult cancer to treat successfully as it frequently remains undiagnosed until it has reached the stage where a patient’s survival chances are low. Accurate earlier diagnosis through Fortel Bca could offer an immediate and significant improvement in the prognosis of those suffering from the disease. The test can also be used by clinicians at regular intervals to monitor the effectiveness of the treatment being given to lung cancer patients.

Medis Diagnostics is looking to raise additional funds of at least £300K to bring Fortel Bca to market. Presenting to an audience of venture capitalists at the BioForum’s investment track, Research and Development Director David Reed said:
“The diagnostic, predictive and classification information provided by Fortel Bca is more powerful than ever seen before. The number of new cases of lung cancer per year almost mirrors the number of deaths and there is a definite and proven need for our technology.”

This is the first time the annual White Rose University Consortium Bioscience Forum has held an investment track. The track is being run by Connect Yorkshire, an organisation that specialises in training and mentoring for high- tech companies seeking finance. Connect Yorkshire also organises twice-yearly investment conferences to bring technology companies together with potential investors.

Simon Browning, managing director of Connect Yorkshire says: “Clearly Medis Diagnostics has technology that will significantly change the outlook for those suffering from, or potentially suffering from lung cancer. Early diagnosis and novel monitoring methods will make an enormous difference to thousands of individuals in the future, demonstrating the importance of new technology in improving quality of life for all of us.”

Simon Donoghue, acting chief executive of the White Rose University Consortium says: “The investment track has demonstrated to delegates the wealth of novel bioscience research being undertaken in the region. We hope that this opportunity will result in further funding for the companies allowing their technologies to be developed further.”

Media Contact

Clare Elsley alfa

More Information:

http://www.whiterose.ac.uk

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Compact QKD system

… paves the way to cost-effective satellite-based quantum networks. Researchers demonstrate successful quantum key distribution between space lab and four ground stations. Researchers report an experimental demonstration of a space-to-ground…

Exploring quantum electron highways with laser light

Spiraling laser light reveals how topological insulators lose their ability to conduct electric current on their surfaces. Topological insulators, or TIs, have two faces: Electrons flow freely along their surface…

First image of antigen-bound T-cell receptor at atomic resolution

Immune system: Antigen binding does not trigger any structural changes in T-cell receptors – Signal transduction probably occurs after receptor enrichment. The immune system of vertebrates is a powerful weapon…

Partners & Sponsors